Squarepoint’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $129K | Buy |
+78,474
| New | +$129K | ﹤0.01% | 2438 |
|
|
2021
Q2 | – | Sell |
-977
| Closed | -$120K | – | 3075 |
|
|
2021
Q1 | $120K | Sell |
977
-6,586
| -87% | -$809K | ﹤0.01% | 2316 |
|
|
2020
Q4 | $860K | Buy |
7,563
+6,953
| +1,140% | +$791K | 0.01% | 1179 |
|
|
2020
Q3 | $73K | Buy |
+610
| New | +$73K | ﹤0.01% | 2169 |
|
|
2020
Q1 | – | Sell |
-278
| Closed | -$93K | – | 2498 |
|
|
2019
Q4 | $93K | Sell |
278
-175
| -39% | -$58.5K | ﹤0.01% | 2260 |
|
|
2019
Q3 | $146K | Sell |
453
-53
| -10% | -$17.1K | ﹤0.01% | 2038 |
|
|
2019
Q2 | $218K | Buy |
506
+228
| +82% | +$98.2K | ﹤0.01% | 2008 |
|
|
2019
Q1 | $157K | Buy |
278
+80
| +40% | +$45.2K | ﹤0.01% | 1935 |
|
|
2018
Q4 | $59K | Sell |
198
-187
| -49% | -$55.7K | ﹤0.01% | 1825 |
|
|
2018
Q3 | $273K | Buy |
+385
| New | +$273K | ﹤0.01% | 1584 |
|